CPRX Operating Cash Flow (Statement)
Catalyst Pharmaceuticals Inc · Operating Cash Flow (Statement)
CPRX Operating Cash Flow (Statement)
Latest reported$208.21Mperiod ending
CPRX TTM Cash from Operations (-$4.42M → $208.21M)
TTM operating cash flow (statement)
High-resolution chart · PNG
CPRX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 208,214,000 | |
| 208,670,000 | |
| 234,656,000 | |
| 275,089,000 | |
| 267,926,000 | |
| 239,808,000 | |
| 224,579,000 | |
| 196,836,000 | |
| 163,455,000 | |
| 143,600,000 | |
| 128,029,000 | |
| 124,202,000 | |
| 119,639,000 | |
| 116,047,000 | |
| 95,146,000 | |
| 75,552,000 | |
| 65,036,000 | |
| 60,372,000 | |
| 54,301,567 | |
| 44,045,676 | |
| 41,635,786 | |
| 45,034,864 | |
| 44,220,738 | |
| 49,032,246 | |
| 49,787,306 | |
| 34,611,473 | |
| 14,006,502 | |
| -9,059,145 | |
| -27,585,711 | |
| -25,704,406 | |
| -21,420,743 | |
| -17,250,554 | |
| -15,945,147 | |
| -13,742,572 | |
| -14,124,444 | |
| -14,769,629 | |
| -15,912,160 | |
| -17,963,503 | |
| -18,183,086 | |
| -20,248,253 | |
| -20,150,470 | |
| -18,015,221 | |
| -17,363,854 | |
| -15,573,585 | |
| -14,311,708 | |
| -12,941,783 | |
| -13,092,087 | |
| -11,223,150 | |
| -10,051,514 | |
| -9,875,674 | |
| -7,339,201 | |
| -6,756,148 | |
| -6,088,279 | |
| -5,140,366 | |
| -4,984,776 | |
| -5,136,482 | |
| -5,455,221 | |
| -4,985,049 | |
| -4,316,005 | |
| -3,880,709 | |
| -3,566,936 | |
| -3,757,405 | |
| -3,817,159 | |
| -4,353,046 | |
| -5,868,165 | |
| -7,683,189 | |
| -9,754,999 | |
| -10,922,025 | |
| -9,872,995 | |
| -8,260,412 | |
| -6,292,045 | |
| -4,463,909 | |
| -4,283,314 | |
| -4,424,934 | |
| -4,170,236 | |
| -3,544,469 |